Parkland Medical Center is an 86-bed hospital in Derry, New Hampshire with an urgent care center in Salem. Parkland was established in 1983 and is part of the Hospital Corporation of America.

There are 86 beds in Parkland Medical Center.

During the past decade, Parkland Medical Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Parkland Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 4 trials, followed by "Harvard Pilgrim Health Care" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored, "SWOG Cancer Research Network" with 1 trials sponsored and "University of California, Irvine" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Parkland Medical Center" #1 collaborator was "Centers for Disease Control and Prevention" with 4 trials as a collaborator, "Rush University" with 3 trials as a collaborator, "University of California, Irvine" with 3 trials as a collaborator, "Hospital Corporation of America" with 2 trials as a collaborator and "National Cancer Institute (NCI)" with 2 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Parkland Medical Center" are "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (2 trials), "Stage II Lung Non-Small Cell Cancer AJCC v7" (2 trials), "Stage IIA Lung Non-Small Cell Carcinoma AJCC v7" (2 trials), "Stage IIB Lung Non-Small Cell Carcinoma AJCC v7" (2 trials) and "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (2 trials). Many other conditions were trialed in "Parkland Medical Center" in a lesser frequency.

Most popular intervention types in "Parkland Medical Center" are "Drug" (9 trials), "Other" (7 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "Clinical Observation" (3 trials), "Crizotinib" (2 trials), "Placebo Administration" (2 trials) and "Quality-of-Life Assessment" (2 trials). Other intervention names were less common.

The vast majority of trials in "Parkland Medical Center" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Parkland Medical Center". undefined are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Parkland Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Parkland Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".